---
title: "Acadia Pharmaceuticals CFO Mark C. Schneyer disposes of 25,141 common shares worth $730,047.52"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295281807.md"
description: "Acadia Pharmaceuticals CFO Mark C. Schneyer sold 20,141 shares at an average price of $29 on August 5-6, exercising options to cover the sales. This transaction reduced his stake to 67,828 shares."
datetime: "2026-08-07T22:00:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295281807.md)
  - [en](https://longbridge.com/en/news/295281807.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295281807.md)
generator: "portal-rs"
---

# Acadia Pharmaceuticals CFO Mark C. Schneyer disposes of 25,141 common shares worth $730,047.52

-   ACADIA Pharmaceuticals CFO Mark C. Schneyer cut his stake to 67,828 shares in transactions dated Aug. 5-6. \* Sold 20,141 shares at prices around $29, including a weighted-average sale price of $29. \* Exercised options for 20,141 shares at $17.84 to cover the sales. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001899977-26-000008), on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ACAD.US](https://longbridge.com/en/quote/ACAD.US.md)

## Related News & Research

- [GSA Capital Partners LLP Makes New Investment in ACADIA Pharmaceuticals Inc. $ACAD](https://longbridge.com/en/news/296084900.md)
- [ACADIA Pharmaceuticals Expands DAYBUE, NUPLAZID Reach Ahead of Key Alzheimer’s Data](https://longbridge.com/en/news/295699458.md)
- [Mark Schneyer Sells 5,849 Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock](https://longbridge.com/en/news/295283718.md)
- [Acadia Pharmaceuticals Q2 revenue rises on DAYBUE STIX demand, lifts 2026 outlook](https://longbridge.com/en/news/294866410.md)
- [Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference | ACAD Stock News](https://longbridge.com/en/news/294422717.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**